AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30400846 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreeableness
Number of subjects: 1002
Study 26566200 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in patients with tremor-predominant Parkinson disease (PD)
Number of subjects: 4
Study 26566200 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS)
Number of subjects: 4
Study 24745865 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation on PC6 and L14 points (combined group)
Number of subjects: 227
Study 24745865 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture stimulation on PC6 point only (single group)
Number of subjects: 227
Study 22229880 — intervention group
Group type: EXPERIMENTAL
Intervention: Marriage education (PREP)
Number of subjects: 662
Study 22229880 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 662
Study 19605598 — intervention group
Group type: EXPERIMENTAL
Intervention: MRKAd6 HIV type 1 (HIV‐1) trigene vaccine at weeks 0, 4, and 26
Number of subjects: 34
Study 19605598 — intervention group
Group type: EXPERIMENTAL
Intervention: MRKAd5+MRKAd6 (MRKAd5+6) HIV‐1 trigene vaccine at weeks 0, 4, and 26
Number of subjects: 34
Study 17495495 — intervention group
Group type: COMPARATOR
Intervention: Lithotomy position (group 1)
Number of subjects: 70
Study 17495495 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral position (group 2)
Number of subjects: 70
Study 15210599 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR
Number of subjects: 105
Study 15210599 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR (duration >3 minutes)
Number of subjects: 105
Study 12402055 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (2 Gy/day for a total of 70 Gy)
Number of subjects: 10
Study 12402055 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of external beam radiotherapy (50 Gy, 2 Gy/day) and high dose rate brachytherapy (two 10-Gy fractions)
Number of subjects: 10
Study 12402055 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 10
Study 10451461 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (600,000 U intramuscularly at enrollment and at 12 weeks)
Number of subjects: 123
Study 10451461 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg daily)
Number of subjects: 123
Study 10451461 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Vitamin D and Calcium)
Number of subjects: 123
Study 10451461 — intervention group
Group type: COMPARATOR
Intervention: Control group (children without rickets)
Number of subjects: 123
Study 7587987 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate (Elocon)
Number of subjects: 0
Study 7587987 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (Cutivate)
Number of subjects: 0
Study 2141491 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol Acetate (MA) 2 X 80 mg p.o. daily
Number of subjects: 98
Study 2141491 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone Acetate (MPA) 2 X 500 mg p.o. daily
Number of subjects: 98
Study 695649 — intervention group
Group type: EXPERIMENTAL
Intervention: Perhexiline
Number of subjects: 20
Study 695649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30548844 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemofiltration for 36 hours
Number of subjects: 37
Study 30548844 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 37
Study 28218483 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate with alcohol (CHX+)
Number of subjects: 20
Study 28218483 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate without alcohol (CHX-)
Number of subjects: 20
Study 28218483 — intervention group
Group type: COMPARATOR
Intervention: Sterile flavoured-mint physiological saline (control)
Number of subjects: 20
Study 25422168 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational needs assessment tool-focused education
Number of subjects: 16
Study 25422168 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 16
Study 23350644 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU vitamin D daily (Group A)
Number of subjects: 120
Study 23350644 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU vitamin D monthly (Group B)
Number of subjects: 120
Study 23350644 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU vitamin D every 2 weeks (Group C)
Number of subjects: 120
Study 23350644 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 120
Study 22178838 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: 14 Fr silicon tube (Urovision) with balloon
Number of subjects: 72
Study 22178838 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II: 14 Fr silicon tube (Urovision) without balloon
Number of subjects: 72
Study 22178838 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III: 20 Fr latex tube without balloon
Number of subjects: 72
Study 22178838 — intervention group
Group type: COMPARATOR
Intervention: Control: Not applicable
Number of subjects: 72
Study 19690349 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD0837 (150 mg once daily)
Number of subjects: 955
Study 19690349 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD0837 (300 mg once daily)
Number of subjects: 955
Study 19690349 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD0837 (200 mg twice daily)
Number of subjects: 955
Study 19690349 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD0837 (450 mg once daily)
Number of subjects: 955
Study 19690349 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD0837 (150, 300, 450 mg once daily or 200 mg twice daily)
Number of subjects: 955
Study 19690349 — intervention group
Group type: COMPARATOR
Intervention: VKA (international normalized ratio 2‐3, target 2.5)
Number of subjects: 955
Study 19690349 — intervention group
Group type: COMPARATOR
Intervention: VKA
Number of subjects: 955
Study 16456412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nominal starting dose of PEG 4000
Number of subjects: 96
Study 16456412 — intervention group
Group type: COMPARATOR
Intervention: Double starting dose of PEG 4000
Number of subjects: 96
Study 16456412 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 4000 treatment
Number of subjects: 96
Study 17136986 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 mcg daily
Number of subjects: 2128
Study 17136986 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 36 mcg daily
Number of subjects: 2128
Study 17136986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2128
Study 15550144 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod (5 days per week for 1, 2, or 4 weeks)
Number of subjects: 16
Study 15550144 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 weeks)
Number of subjects: 16
Study 10404354 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (12.5 mg, titrated to 50 mg once daily)
Number of subjects: 3152
Study 10404354 — intervention group
Group type: COMPARATOR
Intervention: Captopril (12.5 mg, titrated to 50 mg thrice daily)
Number of subjects: 3152
Study 8603160 — intervention group
Group type: EXPERIMENTAL
Intervention: soaking cleanser at 50 degrees C
Number of subjects: 80
Study 8603160 — intervention group
Group type: COMPARATOR
Intervention: toothbrush/paste
Number of subjects: 80
Study 8603160 — intervention group
Group type: COMPARATOR
Intervention: brush with soap and water
Number of subjects: 80
Study 8603160 — intervention group
Group type: COMPARATOR
Intervention: all materials
Number of subjects: 80
Study 2390397 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity training programme for one year
Number of subjects: 40
Study 2390397 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (beta blocker)
Number of subjects: 40
Study 7013510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprecipitated plasma
Number of subjects: 176
Study 7013510 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma protein fraction
Number of subjects: 176
Study 7013510 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum albumin solution
Number of subjects: 176
Study 29723001 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation app
Number of subjects: 238
Study 29723001 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 238
Study 28107807 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta-burst stimulation (cTBS) at 80% resting motor threshold
Number of subjects: 12
Study 28107807 — intervention group
Group type: COMPARATOR
Intervention: Active control group receiving cTBS at 40% resting motor threshold
Number of subjects: 12
Study 25886554 — intervention group
Group type: EXPERIMENTAL
Intervention: Rights-based curriculum
Number of subjects: 1750
Study 25886554 — intervention group
Group type: COMPARATOR
Intervention: Basic sex education (control) curriculum
Number of subjects: 1750
Study 24176451 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 8943
Study 24176451 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide
Number of subjects: 8943
Study 24176451 — intervention group
Group type: COMPARATOR
Intervention: Control (no valsartan, no nateglinide)
Number of subjects: 8943
Study 24176451 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline fasting glucose increment
Number of subjects: 8943
Study 24176451 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 8943
Study 21377656 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 25
Study 21377656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 19450912 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with Depression course (CWD)
Number of subjects: 25
Study 17846945 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined temporal clear corneal phacoemulsification and limbal relaxing incisions (LRIs)
Number of subjects: 62
Study 17846945 — intervention group
Group type: COMPARATOR
Intervention: Temporal clear corneal phacoemulsification
Number of subjects: 62
Study 15472775 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettage and autologous bone grafting
Number of subjects: 12
Study 15472775 — intervention group
Group type: EXPERIMENTAL
Intervention: Homologous bone grafting
Number of subjects: 12
Study 15472775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed autologous-homologous bone grafting
Number of subjects: 12
Study 15472775 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettage only
Number of subjects: 12
Study 15472775 — intervention group
Group type: COMPARATOR
Intervention: Control group (asymptomatic patients)
Number of subjects: 12
Study 11547366 — intervention group
Group type: EXPERIMENTAL
Intervention: All-polyethylene tibial components
Number of subjects: 48
Study 11547366 — intervention group
Group type: COMPARATOR
Intervention: Metal-backed tibial components
Number of subjects: 48
Study 9603382 — intervention group
Group type: EXPERIMENTAL
Intervention: First Definite Apical Clearance Lens (FDACL)
Number of subjects: 1209
Study 9603382 — intervention group
Group type: EXPERIMENTAL
Intervention: Steep keratometric reading
Number of subjects: 1209
Study 9603382 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat keratometric reading
Number of subjects: 1209
Study 7826785 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 5 micrograms kg‐1
Number of subjects: 60
Study 7826785 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 10 micrograms kg‐1
Number of subjects: 60
Study 7826785 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 15 micrograms kg‐1
Number of subjects: 60
Study 29044915 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-discharge troponin elevation (>0.04 ng/mL)
Number of subjects: 1469
Study 29044915 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month troponin elevation (>0.04 ng/mL)
Number of subjects: 1469
Study 27525531 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive (150 μg levonorgestrel and 30 μg ethinylestradiol)
Number of subjects: 340
Study 27525531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 25380007 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy
Number of subjects: 49
Study 25380007 — intervention group
Group type: COMPARATOR
Intervention: Standard open wound care
Number of subjects: 49
Study 23422754 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus docetaxel
Number of subjects: 736
Study 23422754 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 736
Study 19901115 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine + pertuzumab
Number of subjects: 130
Study 19901115 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine + placebo
Number of subjects: 130
Study 19901115 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine + pertuzumab (in patients with low HER3 mRNA expression)
Number of subjects: 130
Study 18212333 — intervention group
Group type: EXPERIMENTAL
Intervention: Social interaction (10 min)
Number of subjects: 0
Study 18212333 — intervention group
Group type: EXPERIMENTAL
Intervention: Social interaction (amount of actual social contact)
Number of subjects: 0
Study 17008561 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxford House
Number of subjects: 150
Study 17008561 — intervention group
Group type: COMPARATOR
Intervention: Usual-care condition (outpatient treatment or self-help groups)
Number of subjects: 150
Study 14753595 — intervention group
Group type: EXPERIMENTAL
Intervention: STI‐571 (Gleevec)
Number of subjects: 7
Study 11079255 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA diet (39% of energy as fat and 21 E% monoenes)
Number of subjects: 18
Study 11079255 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-fat diet (34 E% fat, 16 E% monoenes)
Number of subjects: 18
Study 11079255 — intervention group
Group type: COMPARATOR
Intervention: Both diets compared to baseline diet (high in saturated fat)
Number of subjects: 18
Study 8844228 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 1.5 mg/kg per h continuously for 5 days after a loading dose of 600 mg
Number of subjects: 52
Study 8844228 — intervention group
Group type: COMPARATOR
Intervention: Saline solution as placebo (control)
Number of subjects: 52
Study 1581786 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance plethysmography
Number of subjects: 193
Study 3922068 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% sodium cromoglycate nasal spray (group 1)
Number of subjects: 51
Study 3922068 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% sodium cromoglycate plus 0.2% chlorpheniramine nasal spray (group 2)
Number of subjects: 51
Study 31479035 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 24
Study 31479035 — intervention group
Group type: COMPARATOR
Intervention: Combined Training (CT)
Number of subjects: 24
Study 29345398 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (self-selected music using ear-bud headphones during the procedure)
Number of subjects: 60
Study 29345398 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music during the procedure)
Number of subjects: 60
Study 27015667 — intervention group
Group type: EXPERIMENTAL
Intervention: Splint removal on the 3rd day after septoplasty
Number of subjects: 109
Study 27015667 — intervention group
Group type: EXPERIMENTAL
Intervention: Splint removal on the 5th day after septoplasty
Number of subjects: 109
Study 27015667 — intervention group
Group type: EXPERIMENTAL
Intervention: Splint removal on the 7th day after septoplasty
Number of subjects: 109
Study 24400593 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered method (three-minute pressure to sciatic nerves applied by patients themselves)
Number of subjects: 172
Study 24400593 — intervention group
Group type: COMPARATOR
Intervention: Hand pressure method (three-minute pressure to sciatic nerves applied by hands)
Number of subjects: 172
Study 22845895 — intervention group
Group type: EXPERIMENTAL
Intervention: bup100 (300 mg)
Number of subjects: 10
Study 22845895 — intervention group
Group type: COMPARATOR
Intervention: pla (200 mg)
Number of subjects: 10
Study 22845895 — intervention group
Group type: EXPERIMENTAL
Intervention: bup50 (150 mg) and bup75 (225 mg)
Number of subjects: 10
Study 19931549 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg cortisol (administered in a double-blind, placebo-controlled crossover design)
Number of subjects: 20
Study 19931549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 18817234 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (20 mL of 2% lidocaine and 0.9% saline)
Number of subjects: 166
Study 18817234 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 166
Study 16274097 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg/day for 4 months
Number of subjects: 30
Study 16274097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 15493242 — intervention group
Group type: EXPERIMENTAL
Intervention: SP/LPA (speech discrimination, letter‐sound correspondence, and phonemic awareness)
Number of subjects: 35
Study 15493242 — intervention group
Group type: EXPERIMENTAL
Intervention: LPA (letter‐sound correspondence and phonemic awareness)
Number of subjects: 35
Study 15493242 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 10207461 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 340
Study 10207461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 7868909 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐1 and IL‐1 receptor antagonist (IL‐1ra) production in IBD patients
Number of subjects: 0
Study 7868909 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 7868909 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐1ra/IL‐1 ratio
Number of subjects: 0
Study 7868909 — intervention group
Group type: COMPARATOR
Intervention: Self-limiting colitis patients
Number of subjects: 0
Study 1720336 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloids (6% HES 200/0.5)
Number of subjects: 60
Study 1720336 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloids (Ringer's solution)
Number of subjects: 60
Study 1720336 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid replacement with hemofiltration (HF)
Number of subjects: 60
Study 1720336 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid replacement with cell saver (CS)
Number of subjects: 60
Study 348294 — intervention group
Group type: EXPERIMENTAL
Intervention: CCNU
Number of subjects: 109
Study 348294 — intervention group
Group type: COMPARATOR
Intervention: methyl‐CCNU
Number of subjects: 109
Study 29571271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Home‐Life Intervention
Number of subjects: 242
Study 30685834 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with ketamine 0.75 mg/kg (KE0.75)
Number of subjects: 90
Study 30685834 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with ketamine 1.5 mg/kg (KE1.5)
Number of subjects: 90
Study 30685834 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 90
Study 30685834 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with ketamine
Number of subjects: 90
Study 27659126 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein meals during dialysis (50-55 g) combined with lanthanum carbonate
Number of subjects: 110
Study 27659126 — intervention group
Group type: COMPARATOR
Intervention: Low-protein meals during dialysis (<1 g)
Number of subjects: 110
Study 27659126 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein meals during dialysis
Number of subjects: 110
Study 27659126 — intervention group
Group type: COMPARATOR
Intervention: Low-protein meals during dialysis
Number of subjects: 110
Study 26054553 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 150 mg
Number of subjects: 733
Study 26054553 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg
Number of subjects: 733
Study 26054553 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg (GLACIAL)
Number of subjects: 733
Study 26054553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 733
Study 24982463 — intervention group
Group type: EXPERIMENTAL
Intervention: NCRT followed by surgery (45 Gy in 25 fractions over 5 weeks with fluorouracil 800 mg/m2 and cisplatin 75 mg/m2)
Number of subjects: 195
Study 24982463 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 195
Study 22869065 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (tesamorelin) 1 mg/d
Number of subjects: 152
Study 22869065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 19741312 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise (1 hour twice a week for 12 months)
Number of subjects: 36
Study 19741312 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 36
Study 19741312 — intervention group
Group type: COMPARATOR
Intervention: Counseling alone
Number of subjects: 36
Study 17539946 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 17539946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15866358 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg
Number of subjects: 36
Study 15866358 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 36
Study 15866358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 11931698 — intervention group
Group type: EXPERIMENTAL
Intervention: Etimicin alone
Number of subjects: 10
Study 11931698 — intervention group
Group type: COMPARATOR
Intervention: Etimicin with piperacillin
Number of subjects: 10
Study 9820740 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU) based chemoradiation regimen
Number of subjects: 0
Study 9820740 — intervention group
Group type: EXPERIMENTAL
Intervention: New chemotherapeutic agents (gemcitabine)
Number of subjects: 0